We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
348 result(s) found, displaying 261 to 270
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationPriority review
-
Designation or determinationProvisional approval
-
Prescription medicine registrationActive ingredients: ertugliflozin.
-
Prescription medicine registrationActive ingredients: ertugliflozin and sitagliptin phosphate monohydrate.
-
Prescription medicine registrationActive ingredients: ertugliflozin and metformin hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial.
-
Designation or determinationPriority review
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NOXAFIL posaconazole 100mg modified release tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack.